These abstracts on Wellmune are part of published research in peer-reviewed science and medical journals.
Wellmune® Preclinical Research
Differential Pathways Regulating Innate and Adaptive Anti-tumor Immune Responses by Particulate and Soluble Yeast-derived β-Glucans
Therapeutic Potential of Various β-glucan Sources in Conjunction with Anti-tumor Monoclonal Antibody in Cancer Therapy
Cancer Biology & Therapy. 8:3, 216-223; 1 February 2009.
Yeast ß-Glucan Amplifies Phagocyte Killing of iC3b-Opsonized Tumor Cells via Complement Receptor 3-Syk-Phosphatidylinositol 3-Kinase Pathway1
The Journal of Immunology. 2006 Aug 1;177(3):1661-9
C5a-Mediated Leukotriene B4-Amplified Neutrophil Chemotaxis Is Essential in Tumor Immunotherapy Facilitated by Anti-Tumor Monoclonal Antibody and ß-Glucan1
The Journal of Immunology. 2005 174:7050-7056.
Yeast Whole Glucan Particle β-glucan in Conjunction with Antitumour Monoclonal Antibodies to Treat Cancer
Expert Opinion on Biological Therapy. May 2005, Vol. 5, No. 5, Pages 691-702.
Mechanism by Which Orally Administered ß-1,3-Glucans Enhance the Tumoricidal Activity of AntiTumor Monoclonal Antibodies in Murine Tumor Models
The Journal of Immunology. 2004: 173: 797-806.